Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 1
2010 1
2011 1
2012 1
2013 4
2014 2
2015 1
2016 1
2017 2
2018 4
2019 6
2020 4
2021 4
2022 5
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Mitochondrial fission links ECM mechanotransduction to metabolic redox homeostasis and metastatic chemotherapy resistance.
Romani P, Nirchio N, Arboit M, Barbieri V, Tosi A, Michielin F, Shibuya S, Benoist T, Wu D, Hindmarch CCT, Giomo M, Urciuolo A, Giamogante F, Roveri A, Chakravarty P, Montagner M, Calì T, Elvassore N, Archer SL, De Coppi P, Rosato A, Martello G, Dupont S. Romani P, et al. Among authors: barbieri v. Nat Cell Biol. 2022 Feb;24(2):168-180. doi: 10.1038/s41556-022-00843-w. Epub 2022 Feb 14. Nat Cell Biol. 2022. PMID: 35165418 Free PMC article.
Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma.
Baggi A, Quaglino P, Rubatto M, Depenni R, Guida M, Ascierto PA, Trojaniello C, Queirolo P, Saponara M, Peris K, Spagnolo F, Bianchi L, De Galitiis F, Potenza MC, Proietti I, Marconcini R, Botticelli A, Barbieri V, Licitra L, Alfieri S, Ficorella C, Cortellini A, Fargnoli MC, Troiani T, Tondulli L, Bossi P. Baggi A, et al. Among authors: barbieri v. Eur J Cancer. 2021 Nov;157:250-258. doi: 10.1016/j.ejca.2021.08.018. Epub 2021 Sep 15. Eur J Cancer. 2021. PMID: 34536948
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study.
Tassone P, Di Martino MT, Arbitrio M, Fiorillo L, Staropoli N, Ciliberto D, Cordua A, Scionti F, Bertucci B, Salvino A, Lopreiato M, Thunarf F, Cuomo O, Zito MC, De Fina MR, Brescia A, Gualtieri S, Riillo C, Manti F, Caracciolo D, Barbieri V, Di Paola ED, Di Francesco AE, Tagliaferri P. Tassone P, et al. Among authors: barbieri v. J Hematol Oncol. 2023 Jun 26;16(1):68. doi: 10.1186/s13045-023-01468-8. J Hematol Oncol. 2023. PMID: 37365583 Free PMC article. Clinical Trial.
Diagnosis and first-line treatment of non-small cell lung cancer in the era of novel immunotherapy: recommendations for clinical practice.
De Marinis F, Barberis M, Barbieri V, Marchianò A, Gasparini S, Migliorino MR, Romano G, Spinnato F, Vitiello F, Gridelli C. De Marinis F, et al. Among authors: barbieri v. Expert Rev Respir Med. 2019 Mar;13(3):217-228. doi: 10.1080/17476348.2019.1569517. Epub 2019 Jan 24. Expert Rev Respir Med. 2019. PMID: 30640563 Review.
Hyaluronan is a natural and effective immunological adjuvant for protein-based vaccines.
Dalla Pietà A, Carpanese D, Grigoletto A, Tosi A, Dalla Santa S, Pedersen GK, Christensen D, Meléndez-Alafort L, Barbieri V, De Benedictis P, Pasut G, Montagner IM, Rosato A. Dalla Pietà A, et al. Among authors: barbieri v. Cell Mol Immunol. 2021 May;18(5):1197-1210. doi: 10.1038/s41423-021-00667-y. Epub 2021 Mar 24. Cell Mol Immunol. 2021. PMID: 33762685 Free PMC article.
Long-term proliferation of immature hypoxia-dependent JMML cells supported by a 3D in vitro system.
Cani A, Tretti Parenzan C, Frasson C, Rampazzo E, Scarparo P, Francescato S, Caicci F, Barbieri V, Rosato A, Cesaro S, Zecca M, Micalizzi C, Sainati L, Pigazzi M, Biffi A, Buldini B, Locatelli F, Persano L, Masetti R, Te Kronnie G, Bresolin S. Cani A, et al. Among authors: barbieri v. Blood Adv. 2023 Apr 25;7(8):1513-1524. doi: 10.1182/bloodadvances.2021006746. Blood Adv. 2023. PMID: 36053787 Free PMC article.
38 results